LifePoint Health (LPNT) Misses Q3 EPS by 16c, Miss on Revenues; FY17 EPS/Revenue Outlook Below Consensus
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/30/2026
Go back to LifePoint Health (LPNT) Misses Q3 EPS by 16c, Miss on Revenues; FY17 EPS/Revenue Outlook Below Consensus
October 31, 2017 8:35 AM EDT
Leerink Partners lowered its price target on Lifepoint Holdings (NASDAQ: LPNT) to $58.00 (from $74.00) while maintaining a Outperform rating following the company's 3Q earnings report. The quarter was weak and LPNT's EBITDA margin expansion story was delayed due to physician referral issues impacting the 2016... More
October 30, 2017 8:14 AM EDT
SunTrust Robinson Humphrey lowered its price target on Lifepoint Holdings (NASDAQ: LPNT) to $54.00 (from $60.00) while maintaining a Hold rating following a tough quarter.
...
More
October 30, 2017 4:57 AM EDT
Mizuho Securities lowered its price target on Lifepoint Holdings (NASDAQ: LPNT) to $50.00 (from $58.00) while maintaining a Neutral rating.
Analyst Sheryl Skolnick is fearful as FCF turns negative noting the high capex causing the pressure is not set abate anytime soon. The analyst see LT... More
October 30, 2017 4:55 AM EDT
Raymond James downgraded Lifepoint Holdings (NASDAQ: LPNT) from Outperform to Market Perform.
For an analyst ratings summary and ratings history on Lifepoint Holdings click here. For more ratings news on Lifepoint Holdings click here.
Shares of Lifepoint Holdings closed at $49.28 Friday.
...
More
